aTyr Pharma | LIFE - Koszty Sprzedaży





Koszty Sprzedaży Zmiana Data
Ardelyx USD 4.81M 6.04M 2026-03
aTyr Pharma USD 1.31M 2.04M 2026-03
Biogen USD 945.1M 147.6M 2026-06
Bristol-Myers Squibb USD 7.89B 4.03B 2026-06
Cipla INR 29.71B 3.4B 2026-06
Clal Biotechnology ILS 16.49M 2.64M 2022-06
Compugen USD 1.82M 1.71M 2026-03
CSL USD 3.87B 2.08B 2025-12
Curis USD 314K 9.96M 2025-12
GlaxoSmithKline GBP 2.07B 192M 2026-06
Grifols EUR 1.51B 184.45M 2025-12
Lakefront Biotherapeutics EUR 9.14M 4.35M 2026-06
Novartis USD 3.71B 251M 2026-06
Roche Holding CHF 7.85B 630M 2026-06
United Therapeutics USD 99.5M 33.9M 2026-06